NCT06380881View on ClinicalTrials.gov

PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

July 31, 2025

Conditions
Patients With Bone Metastases
Interventions
DRUG

SHR-2017

SHR-2017

Trial Locations (1)

100142

RECRUITING

Beijing Cancer Hospital, Beijing

All Listed Sponsors
lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY